Searched for
HETERO GROUP
Molnupiravir reduced Covid-linked hospitalisation by over 65%: StudyThe Phase III trial results of Hetero's Movfor (Molnupiravir), presented at the Conference on Retroviruses and Opportunistic Infections (CR...
Hetero Group acquires 600 acres in Hyderabad from US fundIn 2017, it bought 20 acres of land from Puravankara Group for Rs 475 crore in the IT belt of Raidurg.
Hetero gets DCGI nod to manufacture, market Molnupiravir capsulesUnder the licensing deal, Hetero will be allowed to expand access of Molnupiravir in India and in other low-and middle-income countries, fo...
Hetero gets DGCI approval for generic version of tocilizumab for treatment of Covid-19"The Drug Controller General of India (DCGI) has issued for restricted use, Emergency Use Authorisation (EUA) for the generic version of To...
Hetero begins Sputnik V production at Hyderabad facilityIn an interaction with the Russian president Vladimir Putin on Friday through a video conference, Hetero group’s Chairman Dr Bandi Parthasa...
After tablets, Hetero working on antiviral medicine Favipiravir injectionsIf successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...
Hetero launches Favipiravir in India under the brand ‘Favivir’ to treat Covid-19This is the second drug developed by Hetero after Covifor, the generic version of Remdesivir injection to be administered intravenously in ...
Hetero dispatches 10k vials of Remdesivir for Covid-19 treatmentThe Hyderabad-headquartered Hetero said it will dispatch second batch of 10,000 vials of the generic drug in the injectable form (100mg via...
Hetero gets DCGI nod to launch Remdesivir for Covid-19 treatmentHetero will produce and launch the first generic Remdesivir under Covifor brand in India following positive clinical outcomes under a licen...
Hetero launches FDC combination of key HIV drugsThe FDC drug ‘Darunavir+Ritonavir’ is an anti-retroviral medication indicated for the treatment of human immunodeficiency virus (HIV-1) in ...
Puravankara sells 19 acre land in Hyderabad for Rs 475 crorePuravankara said the company is in talks with land owners for forming partnership to develop projects in Hyderabad property market that has...
Hetero gets DCGI approval to market Hepatitis C drugHetero is the first company in India to receive the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from DCGI.
Post Invagen sale, Hetero says to strengthen US operationsCipla said the group, through its subsidiary Camber Pharmaceuticals Inc., will continue to strengthen its operations in the US.
Hetero launches biosimilar Rituximab in IndiaHetero has launched biosimilar Rituximab in India used for treatment of certain types of cancers and rheumatoid arthritis under the brand n...
Hetero launches biosimilar Rituximab in IndiaHyderabad based Hetero pharma has launched biosimilar drug Rituximab under the brand name of MABALL, used in the treatment of blood cancer.
Apollo Hospitals in advanced talks to acquire Hetero PharmacyApollo operates 1,632 pharmacy stores across the country, while Hetero Pharmacy owns 250 outlets spread across Andhra Pradesh, Telangana an...
- Hyderabad's Hetero Group enters UAE with new venture
The first phase of the collaboration will be distribution of Hetero's medicines in the UAE, Chairman of Hetero Group B P S Reddy said.